133 related articles for article (PubMed ID: 7950359)
21. Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011.
Enninga EAL; Moser JC; Weaver AL; Markovic SN; Brewer JD; Leontovich AA; Hieken TJ; Shuster L; Kottschade LA; Olariu A; Mansfield AS; Dronca RS
Cancer Med; 2017 Oct; 6(10):2203-2212. PubMed ID: 28879661
[TBL] [Abstract][Full Text] [Related]
22. A population-based validation of the American Joint Committee on Cancer melanoma staging system.
Gimotty PA; Botbyl J; Soong SJ; Guerry D
J Clin Oncol; 2005 Nov; 23(31):8065-75. PubMed ID: 16258105
[TBL] [Abstract][Full Text] [Related]
23. Clinical stages of cutaneous malignant melanoma in Bulgaria.
Troyanova P; Valerianova Z; Danon S
Neoplasma; 2000; 47(4):257-60. PubMed ID: 11043833
[TBL] [Abstract][Full Text] [Related]
24. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society.
Chang AE; Karnell LH; Menck HR
Cancer; 1998 Oct; 83(8):1664-78. PubMed ID: 9781962
[TBL] [Abstract][Full Text] [Related]
25. Seasonal variation in the occurrence of cutaneous melanoma in Europe: influence of latitude. An analysis using the EUROCARE group of registries.
Boniol M; De Vries E; Coebergh JW; Doré JF;
Eur J Cancer; 2005 Jan; 41(1):126-32. PubMed ID: 15617997
[TBL] [Abstract][Full Text] [Related]
26. Primary genitourinary melanoma: Epidemiology and disease-specific survival in a large population-based cohort.
Sanchez A; Rodríguez D; Allard CB; Bechis SK; Sullivan RJ; Boeke CE; Kuppermann D; Cheng JS; Barrisford GW; Preston MA; Feldman AS
Urol Oncol; 2016 Apr; 34(4):166.e7-14. PubMed ID: 26739672
[TBL] [Abstract][Full Text] [Related]
27. Multicohort model for prevalence estimation of advanced malignant melanoma in the USA: an increasing public health concern.
Lin AY; Wang PF; Li H; Kolker JA
Melanoma Res; 2012 Dec; 22(6):454-9. PubMed ID: 22990665
[TBL] [Abstract][Full Text] [Related]
28. The burden of malignant melanoma--lessons to be learned from Austria.
Monshi B; Vujic M; Kivaranovic D; Sesti A; Oberaigner W; Vujic I; Ortiz-Urda S; Posch C; Feichtinger H; Hackl M; Rappersberger K
Eur J Cancer; 2016 Mar; 56():45-53. PubMed ID: 26802530
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer).
Katalinic A; Kunze U; Schäfer T
Br J Dermatol; 2003 Dec; 149(6):1200-6. PubMed ID: 14674897
[TBL] [Abstract][Full Text] [Related]
30. Is melanoma survival influenced by month of diagnosis?
Savoye I; Jegou D; Kvaskoff M; Rommens K; Boutron-Ruault MC; Coppieters Y; Francart J
Cancer Epidemiol; 2015 Oct; 39(5):727-33. PubMed ID: 26220880
[TBL] [Abstract][Full Text] [Related]
31. Primary melanomas of the esophagus and anorectum: epidemiologic comparison with melanoma of the skin.
Coté TR; Sobin LH
Melanoma Res; 2009 Feb; 19(1):58-60. PubMed ID: 19430407
[TBL] [Abstract][Full Text] [Related]
32. Strong seasonality in the diagnosis of skin melanoma in Italy: the Italian Network of Cancer Registries (AIRTUM) study.
Crocetti E; Guzzinati S; Paci E; Falcini F; Zanetti R; Vercelli M; Rashid I; De Lisi V; Russo A; Vitarelli S; Ferretti S; Mangone L; Cesaraccio R; Tumino R; Busco S; Buzzoni C
Tumori; 2009; 95(6):665-8. PubMed ID: 20210226
[TBL] [Abstract][Full Text] [Related]
33. Incidence of in Situ vs Invasive Melanoma: Testing the "Obligate Precursor" Hypothesis.
Olsen CM; Pandeya N; Rosenberg PS; Whiteman DC
J Natl Cancer Inst; 2022 Oct; 114(10):1364-1370. PubMed ID: 36042554
[TBL] [Abstract][Full Text] [Related]
34. [Prospective epidemiological study on cutaneous melanomas in the Vendée area].
Brisson C; Reynaud-Hautin C; Bure E; Chatal M; Hadet-Riegert M; Rafstedt P; Humeau S; Kerangueven J; Leroux E; Legroux J; Martin MP; Nogues M; Remond L; Ottavy N; Thebaud Y; Patarin M; Clement A; Proux M
Ann Dermatol Venereol; 2003 Dec; 130(12 Pt 1):1121-4. PubMed ID: 14724514
[TBL] [Abstract][Full Text] [Related]
35. [Stage distribution of malignant melanomas in a Hungarian centre].
Tóth V; Somlai B; Hársing J; Hatvani Z; Kárpáti S
Orv Hetil; 2013 Jun; 154(25):969-76. PubMed ID: 23774804
[TBL] [Abstract][Full Text] [Related]
36. Site, histological type, and thickness of primary cutaneous malignant melanoma in western Netherlands since 1980.
van der Spek-Keijser LM; van der Rhee HJ; Tóth G; Van Westering R; Bruijn JA; Coebergh JW
Br J Dermatol; 1997 Apr; 136(4):565-71. PubMed ID: 9155959
[TBL] [Abstract][Full Text] [Related]
37. Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas.
Haenssle HA; Mograby N; Ngassa A; Buhl T; Emmert S; Schön MP; Rosenberger A; Bertsch HP
JAMA Dermatol; 2016 Mar; 152(3):291-8. PubMed ID: 26536613
[TBL] [Abstract][Full Text] [Related]
38. Higher melanoma incidence in coastal versus inland counties in California.
Korgavkar K; Lee KC; Weinstock MA
Melanoma Res; 2014 Jun; 24(3):280-5. PubMed ID: 24681542
[TBL] [Abstract][Full Text] [Related]
39. Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992-2013.
Landow SM; Gjelsvik A; Weinstock MA
J Am Acad Dermatol; 2017 Feb; 76(2):258-263. PubMed ID: 27887797
[TBL] [Abstract][Full Text] [Related]
40. Reporting cutaneous melanoma to cancer registries in the United States.
Hall HI; Jamison P; Fulton JP; Clutter G; Roffers S; Parrish P
J Am Acad Dermatol; 2003 Oct; 49(4):624-30. PubMed ID: 14512907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
